The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of patient age and adjuvant chemotherapy (ACh) as predictor of survival in patients (pts) with resected gastric adenocarcinoma (RGA).
L. Visa
No relevant relationships to disclose
J. J. Grau
No relevant relationships to disclose
M. Caballero
No relevant relationships to disclose
E. Pineda
No relevant relationships to disclose
V. Ortega
No relevant relationships to disclose
L. Gaba
No relevant relationships to disclose
P. Gascon
No relevant relationships to disclose